Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-20 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +10,248 10,248
2024-06-20 Horning Sandra Director Grant or award +4,800 95,287
2024-06-20 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 Patel Sushil Director Grant or award +4,800 20,500
2024-06-20 Patel Sushil Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 Borisy Alexis Director Grant or award +4,800 2,336,294
2024-06-20 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 Kim Lorence H. Director Grant or award +4,800 70,500
2024-06-20 Kim Lorence H. Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 Weber Barbara Director Grant or award +4,800 20,625
2024-06-20 Weber Barbara Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 Borellini Flavia Director Grant or award +4,800 22,434
2024-06-20 Borellini Flavia Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-20 ANDERSON ELIZABETH M Director Grant or award +4,800 20,625
2024-06-20 ANDERSON ELIZABETH M Director Grant or award · Stock Option (Right to Buy) +16,700 16,700
2024-06-17 GOLDSMITH MARK A See Remarks Sale 10b5-1 −11,950 $37.39 $447K 311,885
2024-06-17 Anders Jack Chief Financial Officer Sale 10b5-1 −1,893 $37.39 $71K 101,176
2024-06-17 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,415 $37.39 $165K 136,651
2024-06-17 Kelsey Stephen Michael See Remarks Sale 10b5-1 −3,349 $37.39 $125K 269,073
2024-06-17 Cislini Jeff General Counsel Sale 10b5-1 −1,757 $37.39 $66K 51,487

Page 25 of 29 · 569 trades